Folinic Acid for Prevention of Pemetrexed-induced Toxicity
NCT06010277
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
NSCLC
Mesothelioma
Thymoma
Interventions
DRUG:
Folinic acid
Sponsor
Amphia Hospital
Collaborators
[object Object]